UTAA09
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for UTAA09, covering 2024-05-16 to 2025-05-16. Get the full timeline:
Most recent: Clinical Trial Update: UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies. [EARLY_Phase 1]